These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 24859797

  • 1. A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.
    Day F, Muranyi A, Singh S, Shanmugam K, Williams D, Byrne D, Pham K, Palmieri M, Tie J, Grogan T, Gibbs P, Sieber O, Waring P, Desai J.
    Target Oncol; 2015 Mar; 10(1):99-109. PubMed ID: 24859797
    [Abstract] [Full Text] [Related]

  • 2. Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.
    Rössle M, Sigg M, Rüschoff JH, Wild PJ, Moch H, Weber A, Rechsteiner MP.
    Virchows Arch; 2013 Nov; 463(5):623-31. PubMed ID: 24085553
    [Abstract] [Full Text] [Related]

  • 3. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
    Ilie MI, Long-Mira E, Hofman V, Mouroux J, Vignaud JM, Gauchotte G, Begueret H, Merlio JP, Emile JF, Hébuterne X, Hofman P.
    Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
    Dvorak K, Higgins A, Palting J, Cohen M, Brunhoeber P.
    Pathol Oncol Res; 2019 Jan; 25(1):349-359. PubMed ID: 29127628
    [Abstract] [Full Text] [Related]

  • 5. VE1 immunohistochemistry is an adjunct tool for detection of BRAFV600E mutation: Validation in thyroid cancer patients.
    Rashid FA, Tabassum S, Khan MS, Ansari HR, Asif M, Sheikh AK, Sameer Aga S.
    J Clin Lab Anal; 2021 Feb; 35(2):e23628. PubMed ID: 33305405
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.
    Dvorak K, Aggeler B, Palting J, McKelvie P, Ruszkiewicz A, Waring P.
    Pathology; 2014 Oct; 46(6):509-17. PubMed ID: 25014730
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
    Nakaji Y, Oki E, Nakanishi R, Ando K, Sugiyama M, Nakashima Y, Yamashita N, Saeki H, Oda Y, Maehara Y.
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.
    Anwar MA, Murad F, Dawson E, Abd Elmageed ZY, Tsumagari K, Kandil E.
    J Surg Res; 2016 Jun 15; 203(2):407-15. PubMed ID: 27363650
    [Abstract] [Full Text] [Related]

  • 9. BRAF V600E immunohistochemistry is reliable in primary and metastatic colorectal carcinoma regardless of treatment status and shows high intratumoral homogeneity.
    Bledsoe JR, Kamionek M, Mino-Kenudson M.
    Am J Surg Pathol; 2014 Oct 15; 38(10):1418-28. PubMed ID: 24921639
    [Abstract] [Full Text] [Related]

  • 10. VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.
    Sajanti S, Sirniö P, Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Ristimäki A, Mäkinen MJ.
    Virchows Arch; 2014 Jun 15; 464(6):637-43. PubMed ID: 24722974
    [Abstract] [Full Text] [Related]

  • 11. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
    Estrella JS, Tetzlaff MT, Bassett RL, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR.
    Mol Cancer Ther; 2015 Dec 15; 14(12):2887-95. PubMed ID: 26438153
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma.
    Sun J, Zhang J, Lu J, Gao J, Lu T, Ren X, Duan H, Liang Z.
    Int J Clin Exp Pathol; 2015 Dec 15; 8(11):15072-8. PubMed ID: 26823846
    [Abstract] [Full Text] [Related]

  • 13. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
    Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL.
    Hum Pathol; 2015 Aug 15; 46(8):1101-10. PubMed ID: 26058727
    [Abstract] [Full Text] [Related]

  • 14. A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.
    Huang WK, Kuo TT, Wu CE, Cheng HY, Hsieh CH, Hsieh JJ, Shen YC, Hou MM, Hsu T, Chang JW.
    Asia Pac J Clin Oncol; 2016 Dec 15; 12(4):403-408. PubMed ID: 27488807
    [Abstract] [Full Text] [Related]

  • 15. Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.
    Løes IM, Immervoll H, Angelsen JH, Horn A, Geisler J, Busch C, Lønning PE, Knappskog S.
    Tumour Biol; 2015 Feb 15; 36(2):1003-13. PubMed ID: 25318602
    [Abstract] [Full Text] [Related]

  • 16. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].
    Lyu JJ, Kong YY, Cai X, Shen XX, Lu YW, Ren M.
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug 08; 46(8):548-552. PubMed ID: 28810295
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of immunohistochemistry for the detection of the BRAF V600E mutation in colorectal carcinoma.
    Ioannou M, Papamichali R, Samara M, Paraskeva E, Papacharalambous C, Baxevanidou K, Koukoulis G.
    J BUON; 2016 Aug 08; 21(3):618-25. PubMed ID: 27569082
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.
    Am J Surg Pathol; 2013 Jan 08; 37(1):61-5. PubMed ID: 23026937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.
    Lasota J, Kowalik A, Wasag B, Wang ZF, Felisiak-Golabek A, Coates T, Kopczynski J, Gozdz S, Miettinen M.
    Am J Surg Pathol; 2014 Sep 08; 38(9):1235-41. PubMed ID: 24832158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.